dendritic cell-MART-1 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-012968
A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of MART-1 (melanoma antigen recognized by T-cells), an antigen expressed by melanoma cells. When the altered dendritic cells are returned to the patient, they stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing MART-1.
| Identifier | MLC-T-ONC-012968 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MART-1 peptide-pulsed DC vaccine; MART-1 peptide-pulsed dendritic cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012968",
"term": "dendritic cell-MART-1 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of MART-1 (melanoma antigen recognized by T-cells), an antigen expressed by melanoma cells. When the altered dendritic cells are returned to the patient, they stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing MART-1.",
"synonyms": [
"MART-1 peptide-pulsed DC vaccine",
"MART-1 peptide-pulsed dendritic cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dendritic-cell-mart-1-peptide-vaccine/"
}
Record 5,812 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.